Clinical Trial Update: Adjuvant Chemoradiation and Biomarkers of Response in High-risk Breast Cancer [Phase 2, Phase 3]

View source ↗

Summary

An ongoing Phase 2/3 trial is evaluating adjuvant chemoradiation and biomarkers of response in high-risk breast cancer and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: University of Virginia | Conditions: Breast Cancer, Breast Cancer Stage I | Phase 2, Phase 3 | Status: RECRUITING